Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft

This publication has 6 references indexed in Scilit:

• Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
  Leukemia, 2003
• The eosinophilias, including the idiopathic hypereosinophilic syndrome
  British Journal of Haematology, 2003
• A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
  New England Journal of Medicine, 2003
• Successful non‐myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome
  British Journal of Haematology, 2002
• The World Health Organization (WHO) classification of the myeloid neoplasms
  Blood, 2002
• Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction
  Bone Marrow Transplantation, 1999